Artificial intelligence (AI) is poised to have a significant role in retinal diseases such as age-related macular degeneration (AMD) and geographic......READ MORE
As seen at AAO 2022, multimodal diagnostics promise to usher in a more molecular level analysis paradigm in age-related macular degeneration (AMD) ......READ MORE
As seen at AAO 2022, there is hope that treatments targeting the complement system will soon be available for patients with geographic atrophy (GA)......READ MORE
AAO 2022 proceedings highlighted the importance of understanding the natural history of age-related macular degeneration (AMD) and geographic atrop......READ MORE
Gene therapy has great potential in the treatment of a variety of relatively common retinal diseases. At AAO 2022, presentations on gene therapy in......READ MORE
At AAO 2022, researchers presented positive data from several phase 3 clinical trials in geographic atrophy (GA) secondary to age-related macular d......READ MORE
